Artificial intelligence is rapidly moving beyond experimentation and into GMP-regulated manufacturing environments. As adoption accelerates, regulators and inspectors are paying closer attention to how AI systems are validated, governed and monitored.
How can manufacturers benefit from AI without compromising product quality, patient safety or regulatory compliance?
In this webinar, QbD Group unpacks what deploying an AI system in a GMP environment actually looks like in practice: what inspectors are currently examining, why AI needs deeper ongoing monitoring than traditional computerized systems, and how your existing GMP requirements, like user access, audit trails, and change control, still fully apply to AI-enabled tools.
You don't need to be an AI expert to benefit from this webinar. This session is designed for professionals working in pharmaceutical and biotechnology manufacturing who are responsible for quality, validation or regulatory compliance and want to understand how AI is reshaping GMP expectations.
Whether you're exploring AI initiatives or preparing your organization for future inspections, this webinar will provide practical guidance to help you navigate the evolving regulatory landscape.
QbD Group supports life sciences companies worldwide in achieving the highest quality and safety standards, from idea to patient, with expertise in quality assurance, regulatory compliance, clinical services, and digital solutions.
📅 Date: Tuesday, September 8, 2026
🕑 Time: 10 AM CEST
🌐 Location: Online webinar (free participation)
🎙️ Hosted by: QbD Group
👉 Webinar language: English
/Screenshot_2024-03-20_153228-(1).webp?mode=autocrop&w=1000&h=750&attachmenthistoryguid=1370a86b-869c-4cbb-a8cc-831a74a832f6&v=&focusX=676&focusY=137&c=e8231e38a6626359ce8d03f65f1ed9eeebec1a81c7b27e7896c2e36b97bea758)
